Bruker Corporation (BRKR) : Analyst Rating Update

Bruker Corporation (BRKR) has an average broker rating of 2.25, which is interpreted as a Buy, as rated by 12 equity analysts. Nonetheless, 5 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. Nevertheless, the majority of 6 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 1, which is also a Strong Buy. 1 considers that the stock is a Sell.

Bruker Corporation (BRKR) : 10 Wall Street analysts covering Bruker Corporation (BRKR) believe that the average level the stock could reach for the short term is $29. The maximum price target given is $34 and the minimum target for short term is around $25, hence the standard deviation is calculated at $2.91.

Bruker Corporation (NASDAQ:BRKR): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $22.29 and $22.25 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $23.05. The buying momentum continued till the end and the stock did not give up its gains. It closed at $22.97, notching a gain of 2.77% for the day. The total traded volume was 2,550,482 . The stock had closed at $22.35 on the previous day.

Also, BTIG Research downgrades their rating on the shares of Bruker Corporation (NASDAQ:BRKR). The current rating of the shares is Neutral. Earlier, the shares were rated a Buy by the brokerage firm. The rating by the firm was issued on May 5, 2016. The company shares have rallied 11.30% from its 1 Year high price. On Apr 11, 2016, the shares registered one year high at $29.85 and the one year low was seen on Oct 2, 2015. The 50-Day Moving Average price is $24.90 and the 200 Day Moving Average price is recorded at $25.70.

Bruker Corporation is a designer and manufacturer of life science and materials research systems and associated products that address the needs of a range of customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology and in-vitro diagnostics. The Company operates through two segments: Bruker Scientific Instruments (BSI) and Bruker Energy & Supercon Technologies (BEST). BSI is organized into three operating segments: the Bruker BioSpin Group, the Bruker CALID Group and the Bruker Nano Group. BEST designs, manufactures and distributes superconducting materials. The company maintains technical and manufacturing centers in Europe and North America, and it has sales offices located throughout the world.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.